Search filters

Filters
Clear All

Phase

  • 11
  • 38
  • 28
  • 46
  • 6
  • 50
  • 9
  • 278
  • 490
  • 158
  • 4
  • 31
  • 457
  • 486
  • 6
  • 4
  • 488

Found 492 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years or above
Male
Phase 2
Interventional
This study investigates the effectiveness of different endocrine therapies for treating male breast cancer. This research aims to determine how well male breast cancer responds to preoperative endocrine therapy and which regimen is most effective. Participants will receive treatment with one of four endocrine therapy combinations, including standard treatments like …
Janssen MajesTEC-9
100 years or below
All genders
Phase 3
The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd in multiple myeloma patients.
THRIVE
22 years - 75 years
All genders
THRIVE is an international, multicenter, 2:1 randomized, double blind, sham-controlled study, designed to demonstrate the adjunctive effectiveness and safety of the Therapeutic Intravascular Ultrasound (TIVUS) Renal Denervation System in hypertensive subjects while subjects are maintained off-antihypertensive medications for a 4-week wash-out period before RDN/Sham procedure and 2 months after procedure.
ASCEND CSP
18 years - 99 years
All genders
This is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. 
UPCC 04219 Phase 2 Study of Capecitabine-Temozolomide(CapTem) with yttrium-90 Radioembolization in the Treatment of Patients with Unresectable Metastatic Grade 2/3 Neuroendocrine Tumors
18 years or above
All genders
Phase 2
Interventional
This study investigates the treatment of patients with unresectable metastatic neuroendocrine tumors (NETs) that are primarily located in the liver. The purpose of this study is to evaluate the effectiveness and safety of a combination treatment using Capecitabine-Temozolomide (CapTem) and yttrium-90 (Y90) radioembolization.Participants in the study will receive CapTem, which …
FACT-CRT: Factors Associated with Response to Cardiac Resynchronization Therapy in Heart Failure Patients with Non-LBBB ECG Pattern
18 years - 100 years
All genders
This research study seeks to validate how echocardiogram (echo) data predicts response to cardiac resynchronization therapy (CRT) provided by a CRT device with a defibrillator (CRT-D) in individuals without the heart arrhythmia abnormality left bundle branch block (LBBB). It also aims to identify new variables recorded from electrocardiograms (ECG) or …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety, tolerability, and anti-tumor activity of an investigational medication in adult patients with solid tumors that express MAGE-A4, a specific tumor-associated antigen. The study focuses on individuals with the HLA-A*02:01 tissue marker, which is necessary for participation.Participants will undergo various study procedures to evaluate the maximum …
18 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effectiveness of two investigational medications in treating HER2-negative metastatic breast cancer. The study involves two investigational medications given in sequence, either trastuzumab deruxtecan followed by datopotamab deruxtecan or vice versa, to understand if this approach works for patients who have already tried other similar …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the effects of an investigational medication on individuals with relapsed or refractory multiple myeloma. The purpose of the study is to evaluate the safety, tolerability, and effectiveness of the investigational medication when used alone or in combination with other cancer treatments.Participants in the study will receive the …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and initial effects of an investigational medication in people with advanced or metastatic solid tumors that have changes in the MAPK pathway. The purpose of this study is to understand how the investigational medication affects these tumors and to determine the appropriate dosage for future …
451 - 460 of 492